Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 14, Number 1—January 2008
THEME ISSUE
International Polar Year
Dispatch

Molecular Epidemiology of Dengue Virus Strains from Finnish Travelers

Eili Huhtamo*Comments to Author , Nathalie Y. Uzcátegui*, Heli Siikamäki†, Auli Saarinen*, Heli Piiparinen*, Antti Vaheri*, and Olli Vapalahti*‡§
Author affiliations: *Haartman Institute, University of Helsinki, Finland; †Helsinki University Central Hospital, Finland; ‡HUSLAB Hospital District of Helsinki and Uusimaa, Finland; §Faculty of Veterinary Medicine, University of Helsinki, Finland;

Main Article

Table

Dengue virus isolates from Finnish travelers, 2000–2005*

Virus serotype Patient travel history Year Isolate/ case no. Strain designation (GenBank accession
 no.) IFA screening of infected cells†
Isolation serum antibody status
Patient sex/ age, y
Vero E6
C6/36
dpi Pos dpi Pos dpo IgM IgG
DENV-1 Thailand 2002 3 F9.D1.02
(EU005250) 7 +++ 7 ++ 5 <10 F/23
DENV-1 Malaysia/ Thailand 2002 4 F12.D1.02
(EU005249) 24 + 7 + 20 F/43
DENV-1 Thailand 2005 8 F31.D1.05
(EU005248) 24 + 7 + <10 F/56
DENV-1 India 2005 11 F37.D1.05
(EU005247) 5 +++ 5 +++ 3 NA NA M/31
DENV-2 Sri Lanka 2003 6 F18.D2.03
(EU005252) 24 + 5 + 320 M/54
DENV-2 Ghana 2005 9 F32.D2.05
(C-preM, EU005251;
E, EU005258) 7 +++ 7 + 2 + <10 F/22
DENV-3 Cuba 2002 2 F7.D3.02
(EU005253) 7 + 24 + 6 + 20 M/55
DENV-3 Brazil 2003 5 F13.D3.03
(EU005254) 24 + 5 + <20 M/26
DENV-3 Sri Lanka 2004 7 F24.D3.04
(EU005255) 4 +++ 24 + 2 20 F/39
DENV-4 Sri Lanka 2000 1 F2.D4.00
(EU005256) 10 +++ 10 + 4 + <10 F/42
DENV-4 Indonesia 2005 10 F34.D4.05
(EU005257) 24 + 5 + 20 M/37

*IFA, immunofluoresence assay; dpi, day postinfection; Pos, proportion of positive cells; dpo, day post-onset; Ig, immunoglobulin; DENV, dengue virus; NA, not available; c-preM, capsid–premembrane; E, envelope.
† +, ++, and +++ indicate the relative amount of positive cells observed in IFA using fluorescence microscope: individual positive cells observed <10% (+), 10–50% of the cells positive (++), 50%–100% of the cells positive (+++). –, not detected.

Main Article

Page created: July 08, 2010
Page updated: July 08, 2010
Page reviewed: July 08, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external